Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID

Clinical trial NCT04797260 · SUSPENDED

Trial details

NCT number: NCT04797260
Sponsor: Videja B.V.
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Combined Immunodeficiency Due to RAG1 Deficiency

Start date: 2021-07-23
Primary completion: 2031-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.